medigraphic.com
ISSN 1561-2988 (Print)

2012, Number 4

<< Back Next >>

Rev Cubana Farm 2012; 46 (4)

Factors related to the use of several antibiotics in clinical patients

Mir NI, Guanche GH, Pisonero SJJ, Gutiérrez GG

Language: Spanish
References: 18
Page:
PDF size: 107.03 Kb.


ABSTRACT

Objective: to identify the factors associated to the use of several antibiotics in clinical patients.
Methods: a case-control study of patients with infection, who were discharged from the clinical services at "Joaquín Albarrán" hospital from May, 2008 to December 2011. The patient who used three or more antibiotics was considered as a case. The following data was gathered: age, sex, personal pathological history, onset of suggestive symptoms of an infectious process, previous use of antibiotics, vital signs and state of consciousness on admission, results of hematological and blood chemistry studies, chest X-rays, nosocomial infection diagnosis and inadequate use of antimicrobials. The frequencies were compared by means of the homogeneity test, Fisher´s exact test, t and Wilcoxon tests. Logistic regression for the risk factor identifications was also used.
Results: ninety two cases and 184 controls were studied. The risk of using several antibiotics rose by 2,68 times per each additional centigrade degree that was found to increase the patient's body temperature(OR= 2.68; IC 95 % 1.21-5.94), by 7 times if the level of consciousness was altered (OR= 7.32; IC 95 % 1.88-28.55), by 3.88 times in patients with nosocomial infections and by 9.98 times when the antimicrobials were inadequately used.
Conclusions: the risk factors of the use of several antibiotics can contribute to draw monitoring strategies for the quality of antimicrobial prescription.


REFERENCES

  1. Colectivo de autores. El Manual Merck de Diagnóstico y Tratamiento. 11a ed. Madrid: Elsevier; 2007. p. 1537-70.

  2. Mir Narbona I, Guanche Garcell H, Chappi Estévez Y, Díaz Piñera A, Rodríguez Uribe S, Fiterre Lancis I, et al. Calidad de prescripción de antimicrobianos en servicios seleccionados en hospitales clínico quirúrgicos. Archivos Venezolanos de Farmacología y Terapéutica. 2009;28(2):63-6.

  3. Ranji SR, Steinman MA, Shojania KG, Sundaram V, Lewis R, Arnold S, Gonzales R. Antibiotic Prescribing Behavior. Vol. 4. In: Shojania KG, McDonald KM, Wachter RM, Owens DK, editors. Closing the Quality Gap: A Critical Analysis of Quality Improvement Strategies. Technical Review 9 (Prepared by the Stanford University-UCSF Evidence-based Practice Center under Contract No. 290-02-0017). Stanford: Agency for Healthcare Research and Quality, AHRQ; January 2006. Publication No. 04(06)-0051-4.

  4. Davey P, Brown E, Fenelon L, Finch R, Gould I, Hartman G, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2005 Oct 19;(4):CD003543.

  5. Abal Arca J. Fracaso del tratamiento de la neumonía adquirida en la comunidad, definición y actitud a seguir. Pneuma. 2007;9:25-8.

  6. Menéndez R, Torres A. Treatment failure in community acquired pneumonia. Chest. 2007;132:1348-55.

  7. Menendez R, Torres A, Zalcain R, Aspa J, Martín Villasclaras JJ, Borderias L, et al. Risk factor of treatment failure in community acquired pneumonia: implications for disease outcome. Thorax. 2004;59:960-5.

  8. Rothberg MB, Pekow P, Lahti M, Brody O, Skiest DJ, Lindenauer PK. Antibiotic therapy and treatment failure in patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. JAMA. 2010;303(20):2035-42.

  9. Roson D, Carratala J, Fernandez Sabé N, Tubau F, Manresa F, Gudiol F. Causes and factors associated with early failure in hospitalized patients with community acquired pneumonia. Arch Intern Med. 2004;164:502-8.

  10. Lim WS. Identifying failure of empirical treatment for pneumonia: vigilance and common sense. Thorax. 2004;59:918-9.

  11. Horan TC, Gaynes RP. Surveillance of nosocomial infections. In: Mayhall CG, editor. Hospital Epidemiology and Infection Control. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2004. p.1659-702.

  12. Fiterre Lancis I, Mir Narbona I, Enseñat Sánchez R, Pisonero Sosias J, Pardo Gómez G, Guanche Garcell H. Calidad de prescripción de agentes antimicrobianos en pacientes hospitalizados en servicios clínicos. Rev Cubana Med. 2011 Mar;50(1):49-56.

  13. Lee J, Imanaka Y, Sekimoto M, Ikai H, Otsubo T. Healthcare-associated infections in acute ischaemic stroke patients from 36 Japanese hospitals: risk-adjusted economic and clinical outcomes. Int J Stroke. 2011 Feb;6(1):16-24.

  14. Munita S JM, Araos BR, Pérez GJ, Alvarez VA, Canals CM, Conteras BJ, et al. Bacteremia in patients with liver cirrhosis. Rev Chilena Infectol. 2011 Feb;28(1):35-9.

  15. Izquierdo Cubas F, Zambrano A, Frómeta I, Gutiérrez A, Bastanzuri M, Guanche H, et al. National Prevalence of Nosocomial Infections. Cuba 2004. J Hosp Infect. 2008;68:234-40.

  16. Rosell A, Monso E, Soler N. Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease. Arch Intern Med. 2005;165(8):891-7.

  17. Lawreson RA, Logie JW. Antibiotic failure in the treatment of urinary tract infections in young women. J Antim Chemoth. 2011;48:895-901.

  18. Mistry RD, Scott HF, Zaotis TE, Alpern ER. Emergency department treatment failure for skin infections in the era of community acquired methicillin resistance staphylococcus aureus. Pediatr Emerg Care. 2011;27(1):21-6.




2020     |     www.medigraphic.com